2724
S. K. Mahto, C. S. Chow / Bioorg. Med. Chem. 21 (2013) 2720–2726
the m4Cm nucleoside in 60% overall yield. A series of nine different
oligonucleotide strands containing the m4Cm, m5C, m3U, and Cm
modified nucleotides were generated by 50-BzH-20-ACE solid-phase
(254 lL, 1.8 mmol, 1 equiv to BzH-Cl) to another round-bottom
flask. One millilitre of solution B was added dropwise to solution
A, and the mixture was stirred for 10 min. Every 15 min, 1 mL of
solution B was added dropwise to solution A until solution B was
empty. Reaction progress was monitored by TLC. The reaction
was quenched with 5% NaHCO3 and extracted with CH2Cl2. The or-
ganic layer was washed with brine. The organic layer was dried
over Na2SO4, filtered, and purified on silica gel using 0.5% triethyl-
amine and 30–60% acetone in a hexane solvent gradient to afford 1
in 80% yield (790 mg). 1H NMR (500 MHz, CDCl3) d (ppm) 0.01–
0.03 (m, 18H), 2.84 (s, 3H), 3.62 (s, 3H), 3.80–4.00 (m, 2H), 4.05–
4.17 (m, 3H), 5.13 (d, 1H), 5.90–5.99 (m, 2H), 7.16–7.33 (m, 10H)
7.77 (d, 1H); 13C NMR (125 MHz, CDCl3) d (ppm) 1.61, 1.68, 1.72,
8.83, 28.04, 31.63, 36.70, 46.06, 58.88, 60.99, 61.14, 67.59, 67.79,
83.59, 84.20, 87.85, 94.90, 126.56, 126.64, 126.70, 127.26, 127.40,
127.58, 128.35, 128.49, 139.54, 144.20, 156.21, 164.44; HRMS
calcd for C30H45N3O8NaSi3 682.2412, found 682.2407.
synthesis on a lmol scale. The various oligonucleotide strands hav-
ing site-specifically modified nucleotides were employed in the
generation of a number of different bacterial decoding region mod-
el systems, which enabled biophysical studies to be carried out.
The thermal melting and CD studies provide insight into the struc-
tural role of the modified nucleotides. The m4Cm stabilizing effect
at position 1402 of the decoding region might play a role in stabi-
lizing interactions with helix 45 and mRNA during translation
through enhanced base stacking, as shown in crystal structures.
In contrast, the nucleotide m5C at position 1407 is part of the A-site
dinucleotide bulge where two adenine residues at positions 1492
and 1493 flip out during tRNA recognition. Therefore, it is not sur-
prising that m5C1407 has a destabilizing effect, which may facili-
tate dynamics of the decoding region or interactions with key
components of the translational machinery. Future experimenta-
tion, such as NMR or single-molecule spectroscopy, would be nec-
essary to verify such a mechanism.
4.1.2. 50-O-Benzhydryloxy-bis(trimethylsilyloxy)silyl-30-O-(N,N-
diisopropylamino)methoxyphosphonyl-N4,20-O-
These results are consistent with earlier studies showing that
modified nucleotides each play unique roles in regulating local
RNA stability, structure, or dynamics. Multiple modifications may
have additive effects on RNA conformation or stability, and the
overall effects may be subtle. Furthermore, the same modified
nucleotide at different or multiple locations within the same RNA
sequence may have additional stabilizing roles, such as m5C in
the T. thermophilus decoding region. The importance of using syn-
thetic approaches combined with biophysical approaches is dem-
onstrated in this study. Future studies such as single molecule
analysis on the different RNA constructs may allow more informa-
tion regarding the individual roles of modified nucleotides to be
gleaned. Ligand binding studies may also reveal whether the mod-
ified nucleotides influence important interactions with antibiotics
in the decoding region.
dimethylcytidine (2)
Compound 1 (330 mg, 0.5 mmol, 1.0 equiv) was added to a
round-bottom flask and dissolved in 2 mL of distilled CH2Cl2, and
the clear solution was stirred for a few minutes. Bis(N,N-diisopro-
pylamino)methoxyphosphine
(400
l
L,
367 mg,
1.4 mmol,
2.8 equiv) and 1-H-tetrazole (18 mg, 0.25 mmol, 0.5 eq) were
added to the clear solution while stirring, and the reaction pro-
ceeded for 12 h under argon. The reaction was quenched with
300 lL ethanol. The reaction was dried on rotary evaporator. The
crude product was purified using a hexanes/acetone/triethylamine
(4:1:0.5%) to hexanes/acetone/triethylamine (2:1:0.5%) solvent
gradient to yield 2 as a clear oil in 75% yield (307 mg). 1H NMR
(500 MHz, CDCl3) d (ppm) 0.01–0.03 (m, 18H), 1.00–1.16 (m,
12H), 2.50, 2.52, 2.54, 2.56 (each as a s, 6H), 3.62 (s, 3H), 3.80–
4.00 (m, 2H), 4.05–4.17 (m, 3H), 5.13 (d, 1H), 5.90–5.99 (m, 2H),
7.16–7.33 (m, 10H) 7.77 (d, 1H); 13C NMR (125 MHz, CDCl3) d
(ppm) 1.72, 1.74, 1.78, 8.21, 19.24, 19.31, 24.84, 24.89, 24.95,
25.03, 34.68, 43.01, 43.20, 43.25, 43.35, 46.86, 58.80, 83.96,
87.91, 89.03, 126.61, 126.69, 127.41, 128.47, 128.51, 128.57,
139.91, 144.26, 156.25, 164.48; 31P NMR (170 MHz, CDCl3) d
(ppm) 150.74, 151.87; HRMS calcd for C37H61N4O9NaPSi3
843.3382, found 843.3371 (Supplementary Figs. S1–S4).
4. Materials and methods
All reactions were carried out in anhydrous conditions under ar-
gon atmosphere at room temperature, unless noted otherwise. The
1H, 13C, and 31P NMR spectra were recorded on a Varian 400 MHz
or Unity 500 MHz spectrometer. ESI mass spectrometry was done
on a Waters Micromass Zq instrument. MALDI-TOF spectra was ob-
tained on a Bruker Ultraflex MALDI-TOF mass spectrometer. LC–MS
was carried out on a Waters LCT Premier XE. Flash column chroma-
tography was carried out on silica gel 60 (240–400 mesh). All NMR
solvents were from Cambridge Isotope Laboratories, Inc. Tetrazole
was purchased from Glen Research. Benzhydryloxy-bis(trimethyl-
siloxy)chlorosilane (BzH-Cl) was purchased from Dharmacon Re-
search, Inc. (Lafayette, CO). Methylene chloride (CH2Cl2) was
purchased from Fisher and distilled over CaH2. All other chemicals
were purchased from Sigma–Aldrich and Fisher and used without
further purification. The nucleoside m4Cm was prepared as de-
scribed previously.26
4.1.3. Synthesis of the decoding region RNAs
The m4Cm phosphoramidite was sent to Dharmacon Research
Inc. (Lafayette, CO) where the oligonucleotide synthesis was car-
ried out. The bacterial decoding region RNAs (Table S1, Supplemen-
tary data) were each synthesized on a 1 lmol scale.
4.2. RNA deprotection
The removal of protecting groups on the phosphate backbone
and exocyclic amines was carried out immediately after synthesis
of the oligonucleotide. The methyl protecting groups on the phos-
phate backbone were removed by using disodium 2-carbamoyl-2-
cyanoethylene 1,1-dithiolate (S2Na2) while the RNA was still on the
polystyrene support.42 Next, 40% methylamine in water43,44 was
used for deprotection of the exocyclic amines. This reaction also re-
moved the acetyl protection of the 20-bis-acetoxyethyl orthoester
to generate 20-bis-hydroxyethyl orthoester and cleaved the oligo-
nucleotide from the solid support. These steps were done at
Dharmacon Research. The RNAs were obtained as the 20-bis-
hydroxyethyl orthoester protected forms. The 20-orthoester was
4.1. Phosphoramidite synthesis
4.1.1. 50-O-Benzhydryloxy-bis(trimethylsilyloxy)silyl-N4,20-O-
dimethylcytidine (1)
In a round-bottom flask, m4Cm (408 mg, 1.5 mmol, 1 equiv) was
dissolved in 5 mL of anhydrous DMF. To prepare solution A, 5 mL of
distilled CH2Cl2 and 212 lL of diisopropylamine were added to the
solution at 0 °C. Solution B was prepared at 0 °C by adding
benzhydryloxy-bis(trimethylsiloxy)chlorosilane (BzH-Cl) (765 mg,
1.8 mmol, 1.2 equiv), 5 mL of CH2Cl2, and diisopropylamine
deprotected with 400
and pH adjusted to 3.8 with TEMED. The RNA was incubated with
lL of buffer containing 100 mM acetic acid